World's Best Scientists 2026 revealed!
Award Badge
Chemistry
New Zealand
2026

D-Index & Metrics

Chemistry

D-Index
105
Citations
38195
World Ranking
1010
National Ranking
4

William A. Denny publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where William A. Denny sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 853 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

William A. Denny D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where William A. Denny sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 105 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Chemistry in New Zealand Leader Award
  • 2025 - Research.com Chemistry in New Zealand Leader Award
  • 2022 - Research.com Chemistry in New Zealand Leader Award

Overview

William A. Denny is affiliated with the University of Auckland in New Zealand. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in both areas.

Their subfields of study include Molecular Biology, Oncology, Organic Chemistry, Infectious Diseases, and Biomedical Engineering. The main topics in their work concentrate on cancer therapeutics and mechanisms, tuberculosis research and epidemiology, nanoplatforms for cancer theranostics, biochemical and molecular research, advanced breast cancer therapies, nanoparticle-based drug delivery, and glioma diagnosis and treatment.

Their recent publications demonstrate the breadth of their research interests and include:

  • "Tuberculosis Drug Discovery: Challenges and New Horizons" (2022, Journal of Medicinal Chemistry)
  • "Heptamethine Cyanine Dye Mediated Drug Delivery: Hype or Hope" (2020, Bioconjugate Chemistry)
  • "Small-molecule CSF1R kinase inhibitors; review of patents 2015-present" (2020, Expert Opinion on Therapeutic Patents)
  • "Nitroaromatic Hypoxia-Activated Prodrugs for Cancer Therapy" (2022, Pharmaceuticals)
  • "The Use of Heptamethine Cyanine Dyes as Drug-Conjugate Systems in the Treatment of Primary and Metastatic Brain Tumors" (2021, Frontiers in Oncology)

Frequent co-authors with whom William A. Denny has collaborated include:

  • Peter J. Choi
  • Jiney Jose
  • Thomas Park
  • Elizabeth Cooper
  • Mike Dragunow

The scientist has published numerous articles in recurring venues. The most frequent publication venues are:

  • Molecules
  • European Journal of Medicinal Chemistry
  • Journal of Medicinal Chemistry
  • Pharmaceuticals
  • Bioorganic & Medicinal Chemistry Letters

The focus of William A. Denny's work covers complex therapeutic areas including tuberculosis and cancer treatment, utilizing molecular biology techniques and novel chemical approaches. Their studies involve developing small-molecule inhibitors, hypoxia-activated prodrugs, and nanoplatforms aimed at advancing therapeutic delivery mechanisms.

Best Publications

  • Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality

    Denise A. Chan;Patrick D. Sutphin;Phuong Nguyen;Sandra Turcotte

  • Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor

    David W. Fry;Alexander J. Bridges;William A. Denny;Annette Doherty

  • Tyrosine Kinase Inhibitors. 8. An Unusually Steep Structure−Activity Relationship for Analogues of 4-(3-Bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a Potent Inhibitor of the Epidermal Growth Factor Receptor

    Alexander J. Bridges;Hairong Zhou;Donna R. Cody;Gordon W. Rewcastle

  • Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family

    Alexander James Bridges;William Alexander Denny;David Fry;Alan Kraker

  • Potential antitumor agents. 59. Structure-activity relationships for 2-phenylbenzimidazole-4-carboxamides, a new class of "minimal" DNA-intercalating agents which may not act via topoisomerase II.

    William A. Denny;Gordon W. Rewcastle;Bruce C. Baguley

  • Tyrosine kinase inhibitors. 17. Irreversible inhibitors of the epidermal growth factor receptor: 4-(phenylamino)quinazoline- and 4-(phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides bearing additional solubilizing functions.

    J. B. Smaill;G. W. Rewcastle;J. A. Loo;K. D. Greis

  • Prodrug strategies in cancer therapy.

    William A Denny

  • Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor.

    Gordon W. Rewcastle;William A. Denny;Alexander J. Bridges;Hairong Zhou

  • Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics.

    Juli Feigon;William A. Denny;Werner Leupin;David R. Kearns

  • Acridine derivatives as chemotherapeutic agents.

    William A. Denny

  • DNA-intercalating ligands as anti-cancer drugs: prospects for future design.

    Denny Wa

  • Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor.

    J. B. Smaill;B. D. Palmer;G. W. Rewcastle;W. A. Denny

  • A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation.

    Jharna Datta;Kalpana Ghoshal;William A. Denny;Swarna A. Gamage

  • Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.

    Shama Dissanayake;William A Denny;Swarna Gamage;Vijayalekshmi Sarojini

  • POTENTIAL ANTITUMOR AGENTS. 34. QUANTITATIVE RELATIONSHIPS BETWEEN DNA BINDING AND MOLECULAR STRUCTURE FOR 9-ANILINOACRIDINES SUBSTITUTED IN THE ANILINO RING

    B. C. Baguley;W. A. Denny;G. J. Atwell;B. F. Cain

  • Two-dimensional proton nuclear magnetic resonance investigation of the synthetic deoxyribonucleic acid decamer d(ATATCGATAT)2.

    Juli Feigon;Werner Leupin;William A. Denny;David R. Kearns

  • A molecule targeting VHL-deficient Renal Cell Carcinoma that induces autophagy

    Sandra Turcotte;Denise A. Chan;Patrick D. Sutphin;Michael P. Hay

  • Genotoxicity of non-covalent interactions: DNA intercalators.

    Lynnette R. Ferguson;William A. Denny

  • Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.

    Graham J. Atwell;Gordon W. Rewcastle;Bruce C. Baguley;William A. Denny

  • Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling

    Claire Chaussade;Gordon W. Rewcastle;Jackie D. Kendall;William A. Denny

  • Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards.

    David C. Ware;Brian D. Palmer;William R. Wilson;William A. Denny

  • Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids.

    G W Rewcastle;G J Atwell;Z A Li;B C Baguley

  • Mechanism of Action and Preclinical Antitumor Activity of the Novel Hypoxia-Activated DNA Cross-Linking Agent PR-104

    Adam V. Patterson;Dianne M. Ferry;Shelley J. Edmunds;Yongchuan Gu

Frequent Co-Authors

William R. Wilson
William R. Wilson University of Auckland
Bruce C. Baguley
Bruce C. Baguley University of Auckland
Brian D. Palmer
Brian D. Palmer University of Auckland
Lynnette R. Ferguson
Lynnette R. Ferguson University of Auckland
David W. Fry
David W. Fry Pfizer (United States)
Scott G. Franzblau
Scott G. Franzblau University of Illinois at Chicago
Peter R. Shepherd
Peter R. Shepherd University of Auckland
Joseph A. Trapani
Joseph A. Trapani Peter MacCallum Cancer Centre
Louis Maes
Louis Maes University of Antwerp
James W. Sleigh
James W. Sleigh University of Auckland

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in pursuing Chemistry in the USA, exploring related online degrees can open doors to diverse career opportunities. Many choose to complement their science background with fields like criminal justice or paralegal studies, which offer practical applications and stable job prospects.

Understanding how much is criminal justice school helps in planning educational investments wisely. Online criminal justice programs, including online criminal justice associate degree programs, provide flexibility for working students and a solid foundation for careers in law enforcement or legal services.

For those inclined towards legal support roles, understanding paralegal salary expectations is crucial for career planning. Additionally, Chemistry graduates often find lucrative opportunities in the pharmaceutical industry. Careers like pharmaceutical sales representatives are in high demand, with competitive pay—learning how much do pharmaceutical reps make provides valuable insight into this pathway.

Overall, combining chemistry expertise with related online degrees can enhance employability and provide versatile career pathways in science, law, and healthcare sectors.

Best Scientists Citing William A. Denny

Trending Scientists

Recently Published Articles